METASTATIC BLADDER CANCER
Clinical trials for METASTATIC BLADDER CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC BLADDER CANCER trials appear
Sign up with your email to follow new studies for METASTATIC BLADDER CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy plus chemo shows promise for bladder cancer in early trial
Disease control OngoingThis study tests whether adding the immunotherapy drug atezolizumab to standard chemotherapy (gemcitabine and cisplatin) is safe and works better for people with advanced bladder cancer. About 54 participants will receive the combination treatment. The goal is to see if the combo…
Matched conditions: METASTATIC BLADDER CANCER
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Blood test may unlock targeted cancer drug for more patients
Diagnosis OngoingThis study looks at whether a blood test can detect certain genetic changes (FGFR mutations) in patients with advanced bladder cancer better than the standard tissue biopsy. Currently, only patients with these mutations found in tumor tissue can get the drug erdafitinib. The bloo…
Matched conditions: METASTATIC BLADDER CANCER
Sponsor: Bernie Eigl • Aim: Diagnosis
Last updated Jun 27, 2026 08:04 UTC